Chinese Medicine Treatment for Afatinib-Induced Paronychia
Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the we...
Saved in:
Main Authors: | Pei-Yuu Yang, Chen-Jei Tai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/7327359 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Squareflower, Paronychia erecta
by: Debbie Miller, et al.
Published: (2018-10-01) -
Squareflower, Paronychia erecta
by: Debbie Miller, et al.
Published: (2018-10-01) -
Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report
by: Tsaqilah L, et al.
Published: (2025-01-01) -
Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan
by: Jerry Shu-Hung Kuo, et al.
Published: (2025-01-01) -
Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy
by: Guang-dong Sun, et al.
Published: (2016-01-01)